Postprandial Blood Glucose Control With BioChaperone Combo and Insulin Lispro (Humalog) Mix 25 in People With Type 1 Diabetes Mellitus

Trial Profile

Postprandial Blood Glucose Control With BioChaperone Combo and Insulin Lispro (Humalog) Mix 25 in People With Type 1 Diabetes Mellitus

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Insulin glargine/insulin lispro (Primary) ; Insulin neutral protamine lispro/insulin lispro
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Adocia
  • Most Recent Events

    • 16 Sep 2016 Results assessing post-prandial glucose in type 1 diabetes patients, presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes.
    • 08 Sep 2016 According to an Adocia media release, data from this trial were presented at the 52nd European Association for the Study of Diabetes (EASD) Annual Meeting, 2016.
    • 06 Jun 2016 Results will be presented at the American Diabetes Association 76th Scientific Sessions 2016, according to an Adocia media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top